Michal Tomasz Marzec

Michal Tomasz Marzec

Associate Professor


  1. 2007
  2. Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders.

    El-Salem, M., Raghunath, P. N., Marzec, Michal Tomasz, Wlodarski, P., Tsai, D., Hsi, E. & Wasik, M. A., 2007, In : Laboratory Investigation. 87, 1, p. 29-39 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.

    Marzec, Michal Tomasz, Kasprzycka, M., Liu, X., Raghunath, P. N., Wlodarski, P. & Wasik, M. A., 2007, In : Oncogene. 26, 6, p. 813-821 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.

    Marzec, Michal Tomasz, Kasprzycka, M., Liu, X., El-Salem, M., Halasa, K., Raghunath, P. N., Bucki, R., Wlodarski, P. & Wasik, M. A., 2007, In : Oncogene. 26, 38, p. 5606-5614 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. PU.1 activates transcription of SHP-1 gene in hematopoietic cells.

    Wlodarski, P., Zhang, Q., Liu, X., Kasprzycka, M., Marzec, Michal Tomasz & Wasik, M. A., 2007, In : Journal of Biological Chemistry. 282, 9, p. 6316-6323 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 129941679